0329B |
Amphetamines (D/L Differentiation), Blood |
0329FL |
Amphetamines (D/L Differentiation), Fluid |
0329SP |
Amphetamines (D/L Differentiation), Serum/Plasma |
0329U |
Amphetamines (D/L Differentiation), Urine |
0610B |
Benzphetamine as Metabolites, Blood |
0610SP |
Benzphetamine as Metabolites, Serum/Plasma |
0610U |
Benzphetamine as Metabolites, Urine |
2584B |
Methylenedioxyamphetamine, Blood |
2584SP |
Methylenedioxyamphetamine, Serum/Plasma |
2584U |
Methylenedioxyamphetamine, Urine |
2585B |
Methylenedioxymethamphetamine and Metabolite, Blood |
2585SP |
Methylenedioxymethamphetamine and Metabolite, Serum/Plasma |
2585U |
Methylenedioxymethamphetamine and Metabolite, Urine |
2800B |
Lisdexamfetamine as Metabolite, Blood |
2800SP |
Lisdexamfetamine as Metabolite, Serum/Plasma |
2800U |
Lisdexamfetamine as Metabolite, Urine |
2810B |
Methamphetamine and Metabolite, Blood |
2810FL |
Methamphetamine and Metabolite, Fluid |
2810SP |
Methamphetamine and Metabolite, Serum/Plasma |
2810U |
Methamphetamine and Metabolite, Urine |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8600B |
Amphetamines Panel, Blood |
8600FL |
Amphetamines Panel, Fluid |
8600ME |
Amphetamines Panel (Qualitative), Meconium |
8600SP |
Amphetamines Panel, Serum/Plasma |
8600TI |
Amphetamines Panel, Tissue |
8600U |
Amphetamines Panel, Urine |
8890OF |
Amphetamines Panel (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |